In a double-blind trial of chlorpromazine and thiothixene conducted with 79
acutely ill, newly hospitalized schizophrenic patients, chlorpromazine and thiothixene were
shown to be equally effective in producing meaningful symptomatic improvement over an
average period of approximately 3 weeks, as measured by Global Assessments (CGI), BPRS,
and NOSIE.